Intrauterine Vacuum-Induced Hemorrhage-Control Device for Rapid Treatment of Postpartum Hemorrhage.
Mary E D'Alton, Kara M Rood, Marcela C Smid...
https://pubmed.ncbi.nlm.nih.gov/32909970/Actively Recruiting
Led by University of Zurich · Updated on 2026-10-21
380
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to study women who received vacuum-induced tamponade VIT for postpartum hemorrhage PPH at a large hospital over a nine-year period from 2017 to 2025. The study focuses on understanding the long-term effects of VIT on reproductive health, including fertility and potential complications. Since PPH is a major cause of health issues for mothers worldwide, learning about VITs impact is important for better patient care and counseling. The study collects hospital records and follows up with patient questionnaires to gather detailed information on reproductive outcomes. It explores secondary infertility rates, pregnancy results, time to conceive, fertility-related complications, and psychological effects. This observational study does not involve new treatments but reviews past cases treated with VIT at the University Hospital Zurich. Participants provide consent and share their medical history and experiences through questionnaires. Researchers analyze data on fertility and pregnancy outcomes from 2017 to 2025. The findings will help guide future clinical decisions, improve patient information, and support the planning of larger prospective studies. The study continues until October 2027 to ensure thorough long-term follow-up.
CONDITIONS
Long Term Outcome After Use of Vacuum-induced Tamponade for Postpartum Hemorrhage
C
Christian Haslinger, Prof. Dr
S
Stylianos Kalimeris, Dr. med.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Zurich
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (phone or mail contact)
Duration - Up to 9 years (2017 to 2025), with follow-up until 2027
Researchers collect hospital records and follow-up patient questionnaires to assess reproductive outcomes and safety after vacuum-induced tamponade treatment.
Follow-up via questionnaires and record review
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Mary E D'Alton, Kara M Rood, Marcela C Smid...
https://pubmed.ncbi.nlm.nih.gov/32909970/Christian Haslinger, Kathrin Weber, Roland Zimmermann
https://pubmed.ncbi.nlm.nih.gov/34352848/G Fullerton, P J Danielian, S Bhattacharya
https://pubmed.ncbi.nlm.nih.gov/23339709/University of Zurich
Lead Sponsor